9 results
424B5
SMTI
Sanara MedTech Inc
16 Feb 21
Prospectus supplement for primary offering
4:52pm
is obtained, we may be fined, be forced to remove a product from the market or experience other adverse consequences, which would materially harm our
424B5
SMTI
Sanara MedTech Inc
11 Feb 21
Prospectus supplement for primary offering
4:06pm
information. If we violate regulatory requirements at any stage, whether before or after marketing approval or clearance is obtained, we may be fined
- Prev
- 1
- Next